Cargando…
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
The potential involvement of type 2 diabetes mellitus (T2DM) as a risk factor for colon cancer (CC) has been previously reported. While several clinical studies show a higher incidence of CC and a lower survival rate in diabetics, others report no association. Our own experience indicates that diabe...
Autores principales: | Del Puerto‐Nevado, Laura, Minguez, Pablo, Corton, Marta, Solanes‐Casado, Sonia, Prieto, Isabel, Mas, Sebastian, Sanz, Ana Belen, Gonzalez‐Alonso, Paula, Villaverde, Cristina, Portal‐Nuñez, Sergio, Aguilera, Oscar, Gomez‐Guerrero, Carmen, Esbrit, Pedro, Vivanco, Fernando, Gonzalez, Nieves, Ayuso, Carmen, Ortiz, Alberto, Rojo, Federico, Egido, Jesus, Alvarez‐Llamas, Gloria, Garcia‐Foncillas, Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441931/ https://www.ncbi.nlm.nih.gov/pubmed/30628165 http://dx.doi.org/10.1002/1878-0261.12438 |
Ejemplares similares
-
Colon cancer modulation by a diabetic environment: A single institutional experience
por: Prieto, Isabel, et al.
Publicado: (2017) -
Diabetes‐mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
por: Del Puerto‐Nevado, Laura, et al.
Publicado: (2019) -
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
por: González, Nieves, et al.
Publicado: (2017) -
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer
por: Cenigaonandia-Campillo, Aiora, et al.
Publicado: (2021) -
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
por: Manzanares-Martin, Barbara, et al.
Publicado: (2021)